[Frontiers in Bioscience 3, d525-531, June 8, 1998]
Reprints
PubMed
CAVEAT LECTOR




Table of Conents
 Previous Section   Next Section

MECHANISM OF MYCOBACTERIUM AVIUM COMPLEX PATHOGENESIS

Venkata M. Reddy

Department of Medicine, University of Illinois at Chicago, Rm 864, M/C 735, 808 S.Wood st., Chicago, IL 60612

Received 5/4/98 Accepted 5/8/98

6. REFERENCES

1. Wolinsky,E : Nontuberculosis mycobacteria and associated diseases. Am Rev Respir Dis 119, 107-159 (1979).

2. Horsburgh,C.R : Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Eng J Med 324, 1332-1338 (1991).

3. Nightingale, S.D., L.T.Byrd, P.M.Southern, J.D.Jockusch, S.X.Cal, & B.A.Wayne: Mycobacterium avium-intracellulare complex bacteremia in human immunodeficient virus positive patients. J Infect Dis 165, 1082-1085 (1992).

4. Hellyer,T.J.,I.N. Brown, M.B.Taylor, B.W.Allen, & C.S.F.Easmon: Gastrointestinal involvement in Mycobacterium avium-intracellulare infection of patients with HIV. J Infection 26, 55-66 (1993).

5. Jacobson, M.A., P.C.Hopewell, D.M.Yajko, W.K.Hadley, E.Lazarus, P.K.Mohanty, G.W.Modin, D.W. Feigal, P.S. Cusick, & M.A.Sande : Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis 164, 994-998 (1991).

6. Reddy, M.V., P.Kishori, J.Luna-Herrera, J.O.Falkinham, S.Brown, & P.R.J.Gangadharam : Comparison of virulence of Mycobacterium avium complex strains isolated from AIDS and non-AIDS patients. Microbial Pathog 16, 121-130 (1994).

7. Pedrosa, J., M. Florido, Z.M.Kunze, A.G.Castro, F.Portaels, J.McFadden, M.T.Silva, & R. Appelberg : Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice. Clin Exp Immunol 98, 210-216 (1994).

8. Reddy,V.M., J. Luna-Herrera, & P.R.J.Gangadharam : Pathobiological significance of colony morphology in Mycobacterium avium complex. Microbial Pathog 21, 97-109 (1996).

9. Moehring, J.M, & M.R. Solotorovsky : Relationship of colony morphology to virulence to chickens of Mycobacterium avium and the non-photochromogens. Am Rev Respir Dis 92, 704-713 (1965).

10. Schaefer, W.B., L. Davis, & M.L.Cohn : Pathogenicity of transparent, opaque and rough variants of Mycobacterium avium in chickens and mice. Am Rev Respir Dis 102, 499-506 (1970).

11. Kuze, F, & F.Uchihara : Various colony forms of Mycobacterium intracellulare. Eur J Respir Dis 5, 402-410 (1984).

12. Rastogi,N : Recent observations concerning structure and function relationships in the mycobacterial cell envelope: Elaboration of a model in terms of mycobacterial pathogenicity, virulence and drug resistance. Res Microbiol 142, 464-476 (1991).

13. Rastogi,N : Mycobacteria as intracellular pathogens: Current notions of pathogenicity, virulence and drug resistance and their relation to effective therapy. In, D.Raoult (ed) "Antimicrobial agents and intracellular pathogens".CRC press, Boca Raton, FL, p245-300 (1993).

14. Tomioka, H., H.Saito, H.Sato,H., Y.Yamamoto, M.Uchida, & Y.Yamada : Macrophage respiratory burst-triggering activity of transparent and opaque colonial variants of Mycobacterium avium complex. Kekkaku 64, 401-406 (1989).

15. Gangadharam,P.R.J, & C.K. Edwards : Release of superoxide anion from resident and activated peritoneal macrophages infected with Mycobacterium intracellulare. Am Rev Respir Dis 130, 834-838 (1984).

16. Meylan, P.R., D.D.Richman, & R.S. Kronbluth : Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome. Infect Immun 58, 2564-2568 (1990).

17. Michelini-Norris, M.B., D.K.Blanchard, C.A.Pearson, & J.Y. Djeu : Differential release of interleukin IL-alpha, IL-beta and IL-6 from normal human monocytes stimulated with a virulent and an avirulent isogenic variant of Mycobacterium avium-intracellulare complex. J Infect Dis 165, 702-709 (1992).

18. Shiratsuchi,H., Z.Toosi, M.A.Mettler & J.J. Ellner : Colonial morphotypes as determinant of cytokine expression by human monocytes infected with Mycobacterium avium. J Immunol 150, 2945-2954(1993).

19. Robertson, B.D., & T.F.Meyer : Genetic variation in pathogenic bacteria. Trends Genet 8, 422-427 (1992).

20. Gangadharam,P.R.J., V.K.Perumal, D.C.Farhi, and J.LaBrecque : The beige mouse model for Mycobacterium avium complex (MAC) disease: Optimal conditions for the host and parasite. Tubercle 70, 257-271 (1989).

21. Gangadharam,P.R.J., V.K.Perumal, K.Parikh, R.B.Taylor, & D.C. Farhi : Susceptibility of beige mice to Mycobacterium avium-intracellulare infections by different routes of challenge. Am Rev Respir Dis 139, 1098-1104 (1989).

22. Bermudez, L.E., M.Petrofsky, P.Kolonski, & L.S.Young : Animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract. J Infect Dis 165, 266-272 (1992).

23. Mapother, M.E., & J.C.Sanger : In Vitro interaction of Mycobacterium avium with intestinal epithelial cells. Infect Immun 45, 67-73 (1984).

24. Bermudez,L.E., & L.S.Young : Factors affecting invasion of HT-29 and HEp-2 epithelial cells by organisms of the Mycobacterium avium complex. Infect Immun 62, 2021-2026 (1994).

25. Reddy,V.M., & P.R.J.Gangadharam : Differences in infectivity of isogenic variants of Mycobacterium avium by oral route. Tubercle and Lung Dis 75, 158-160 (1994).

26. Jones, B., L.Pascopella & S.Falkow : Entry of microbes into host: using M cells to break the mucosal barrier. Curr Opinion Immuno 7, 474-478 (1995).

27. Cundell,D., H.R.Masure, & E.I.Tuomanen : The molecular basis of penumococcal infection: A hypothesis. Clin Infect Dis 21, S204-12 (1995).

28. Cundell,D., J.N.Weiser, J.Shen, A.Young, & E.I.Tuomanen : Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun 63, 757-761(1995).

29. Svanborg,C., W.Agace, S.Heges, R.Lindstedt, & M.L.Svensson : Bacterial adherence and mucosal cytokine production. Annals N Y Acad Sci 730, 162-181 (1994).

30. Laux.D.C., E.F.McSweegan, T.J.Williams, E.A.Wadolkowski, & P.S.Cohen : Identification and characterization of mouse small intestine mucosal receptors for Escherichia coli K-12(K88ab). Infect Immun 52, 18-25 (1986).

31. Belley,A., K.Keller, J.Grove, & K.Chadee : Interaction of LS174T human colon cancer cell mucins with Entamoeba histolytica: An in vitro model for colonic disease. Gastroenterology 111, 1484-1492 (1996).

32. Damsker,B., & E. Bottone : Mycobacterium avium-intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: Concepts regarding acquisition and pathogenesis. J Infect Dis 151, 179-181 (1985).

33. Klatt.E.C., D.F.Jensen, & P.R.Meyer : Pathology of Mycobacterium avium-intracellulare infection in acquired immunodeficiency syndrome. Hum Pathol 18, 709-714 (1987).

34. Appleberg,R., & A.M.Sarmento : The role of macrophage activation and Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice. Clin Exp Immunol 80, 324-331(1990).

35. Newman,G.W., H.X.Gan, P.L.McCarthy, & H.G.Remold: Survival of human macrophages infected with Mycobacterium avium intracellulare correlates with increased production of tumor necrosis factor-alpha and IL-6. J Immunol 147, 3942-3948 (1991).

36. Denis,M : Tumor necrosis factor and granulocyte macrophage colony stimulating factor stimulate human macrophages to restrict growth of virulent M.avium: Killing effect mechanism depends on the generation of reactive nitrogen intermediates. J Leukocyte Biol 49, 380-387 (1991).

37. Bermudez,L.E., & L.S.Young : Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 140, 3006-3013 (1988).

38. Bermudez,L.E., P.Stevens, P.Kolonoski, M.Wu, & L.S.Young : Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor. J Immunol 143, 2996-3000 (1989).

39. Hubbard,R.D., & F.M.Collins : Immunomodulation of mouse macrophage killing of Mycobacterium avium in vitro. Infect Immun 59, 570-574 (1991).

40. Shiratsuchi,H., J.Johnson, H.Toba, & J.J. Ellner : Strain and donor-related differences in the interaction of Mycobacterium avium with human monocytes and its modulation by interferon-gamma. J Infect Dis 162, 932-938 (1990).

41. Denis,M : Growth of Mycobacterium avium in human monocytes: Identification of cytokines which reduce and enhance intracellular microbial growth. Eur J Immunol 21, 391-395 (1991).

42. Shiratsuchi,H., J.L. Johnston, & J.J.Ellner : Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J Immunol 146, 3165-3170 (1991)

43. Kallenius,G., T.Kivula, K.J.Rydgard, S.E.Hoffner, A.Valentin, B.Asjo, C.Ljungh, U.Sharma, & S.B.Svenson : Human immunodeficiency virus type 1 enhances intracellular growth of Mycobacterium avium in human macrophages. Infect Immun 60, 2453-2458 (1992).

44. Newman,G., T.G.Kelley, H.Gan, O.Kandil, M.J.Newman, P.Pinkston, R.M.Rose, & H.G.Remold : Concurrent infection of human macrophages with HIV-1 and Mycobacterium avium results in decreased cell viability, increased M.avium multiplication and altered cytokine production. J Immunol 151, 2261-2272 (1993).

45. Douvas,G.S., M.H.May, & A.J. Crowle : Transferrin, iron and serum lipids enhance or inhibit Mycobacterium avium replication in human macrophages. J Infect Dis 167, 857-864 (1993).

46. Tsuyuguchi,I., H.Shiratsuchi, Y. Okuda, & Y.Yamamoto: An analysis of in vitro T cell responsiveness in nontuberculous mycobacterial infection. Chest 94, 822-829 (1988).

47. Tsuyuguchi,I., H.Kawasumi, T.Takashima, T.Tsuyuguchi, & S.Kishimoto : Mycobacterium avium-intracellulare complex induced suppression of T-cell proliferation in vitro by regulation of monocyte accessory cell activity. Infect.Immun 58,1369-1378 (1990).

48. Brownback, P.E., & W.W.Barrow : Modified lymphocyte response to mitogens after intraperitoneal injection of glycopeptidolipid antigens from Mycobacterium avium complex. Infect Immun 56, 1044-1050 (1988).

49. Hooper,L.C., & W.W.Barrow : Decreased mitogenic response of murine spleen cells following intraperitoneal injection of serovar-specific glycopeptidolipid antigens from Mycobacterium avium complex. Adv Exp Med Biol 239, 309-325 (1988).

50. Tassell, S.K., M.Pourshafie, E.L.Wright, M.G.Richmond, & W.W.Barrow : Modified lymphocyte response to mitogens induced by the lipopeptide fragment derived from Mycobacterium avium serovar-specific glycopeptides. Infect Immun 60, 706-711 (1992).

51. Edwards, C.K., H.B.Hedegaard, A.Zlotnik, P.R.J.Gangadharam, R.R.Johnston Jr., & M.J.Pabst : Chronic infection due to Mycobacterium intracellulare in mice: Association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon gamma. J Immunol 136, 1820-1827 (1986).

52. Denis,M., & E.O.Gregg : Modulation of Mycobacterium avium growth in murine macrophages: Reversal of unresponsiveness to interferon-gamma by indomethacin or interleukin-4. J Leukocyte Biol 49, 65-72 (1991).

53. Tomioka, H., H.Saito, & K.Satao : Characterization of immunosuppressive macrophage induced in host spleen cells by Mycobacterium avium complex and Mycobacterium tuberculosis infections in mice. Microbiol Immunol 34, 283-297 (1990).

54. Blanchard,D.K., M.B.Michilini-Norris, H.Friedman, & J.Y.Djeu : Lysis of Mycobacteria-infected monocytes by IL-2 activated Killer cells:Role of LFA-1. Cell Immunol 119, 402-411 (1989).

55. Harshan,K.T., & P.R.J. Gangadharam : In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect Immun 59, 2818-2821 (1991).

56. Thorel,M.,& H.L.David : Specific surface antigens of SmT variants of Mycobacterium avium. Infect Immun 43, 438-439 (1984).

57. Prinzis,S.P., B.Rivoire, & P.J.Brennan : Search for the molecular basis of morphological variation in Mycobacterium avium. Infect Immun 62, 1946-1951 (1994).

58. Barrow,W.W., & P.J.Brennan : Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens. J Bacteriol 150, 381-384 (1982).

59. Ratliff, T.L., J.A.McGarr, C.Abou-Zeid, G.A.W.Rook, J.L.Stanford, J.Aslanzadeh, & E.J.Brown : Attachment of mycobacteria to fibronectin-coated surfaces. J Gen Microbiol 134, 1307-1313 (1988).

60. Ofek,I., and R.J.Doyle : Bacterial adhesion to cells and tissues. Chapman and Hall., NY (1994).

61. Abou-Zeid, C., T.L.Ratliff, & H.G.Wiker : Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect Immun 41, 1261-1268 (1988).

62. Ratliff,T.L., J.A.McCarthy, W.B.Telle & E.J.Brown: Purification of mycobacterial adhesin for fibronectin. Infect Immun 61, 1889-1894 (1993).

63. Rao.S.P., K.Ogata, & A.Catanzaro : Mycobacterium avium-intracellulare binds to the integrin receptor (alphavbeta3) on human monocytes and monocyte-derived macrophages. Infect Immun 61, 663-670 (1993).

64. Isberg,R.R : Pathways for the penetration of enteroinvasive yersinia into mammalian cells. Mol Biol Med 7, 73-82 (1990).

65. Falkow,S : Bacterial entry into eukaryotic cells. Cell 65, 1099-1102 (1991).